Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
3 Results for "
LLC355
" in MedChemExpress (MCE) Product Catalog:
Products (3)
3 Results for "LLC355" in MCE Product Catalog:
Cat. No.: HY-162540
Target:
Research Areas:
LLC355 is a discoidin domain receptor 1 (DDR1) ATTEC degrader with a DC50 of 150.8 nM. LLC355 induces DDR1 protein degradation via lysosome-mediated autophagy. LLC355 inhibits the tumorigenicity, migration and invasion abilities of cancer cells, and induces apoptosis. LLC355 is applicable to research related to non-small cell lung cancer and pancreatic cancer .
Cat. No.: HY-187093
CAS No.: 3076856-56-6
Synonyms: DDR1-IN-2-Boc
Research Areas:
7rh-Boc (DDR1-IN-2-Boc) is a DDR1 ligand that can be used for the synthesis of ATTECs, such as LLC355 (HY-162540) .
Cat. No.: HY-187094
CAS No.: 3076856-77-1
Synonyms: DDR1-IN-2-C2-O-Boc
Research Areas:
7rh-C2-O-Boc (DDR1-IN-2-C2-O-Boc) is a DDR1 ligand and linker conjugate that can be used for the synthesis of ATTECs, such as LLC355 (HY-162540) .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
